PARP Expression Is Increased in Astrocytes but Decreased in Motor Neurons in the Spinal Cord of Sporadic ALS Patients

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Neuropathology and Experimental Neurology

• Publication date

  2003-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNEN/62.1.88PMID 12528821
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduction of acute photodamage in skin by topical application of a novel PARP inhibitor.

  2002cited by this paper
• Overexpression of Poly(ADP-ribose) Polymerase Disrupts Organization of Cytoskeletal F-actin and Tissue Polarity inDrosophila *

  2002cited by this paper
• Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis

  2002cited by this paper
• Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve.

  2002cited by this paper
• High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation.

  2002cited by this paper
• Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice.

  2001cited by this paper
• Na+ dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) in primary astrocyte cultures: effect of oxidative stress.

  2001cited by this paper
• Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis.

  2001cited by this paper
• Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.

  2001cited by this paper
• Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death

  2001cited by this paper
• Damage to nuclear DNA in Lewy body disease

  2001cited by this paper
• Inducible Nitric Oxide Synthase (iNOS) and Nitrotyrosine Immunoreactivity in the Spinal Cords of Transgenic Mice with a G93A Mutant SOD1 Gene

  2001cited by this paper
• PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites

  2001cited by this paper
• Copper chaperone for superoxide dismutase co-aggregates with superoxide dismutase 1 (SOD1) in neuronal Lewy body-like hyaline inclusions: an immunohistochemical study on familial amyotrophic lateral sclerosis with SOD1 gene mutation

  2001cited by this paper
• Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients.

  2001cited by this paper
• Immunocytochemical study on the distribution of nitrotyrosine in the brain of the transgenic mice expressing a human Cu/Zn SOD mutation.

  2000cited by this paper
• Increased oxidative damage to DNA in ALS patients.

  2000cited by this paper
• iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis.

  2000cited by this paper
• The poly(ADP‐ribose) glycohydrolase inhibitor gallotannin blocks oxidative astrocyte death

  2000cited by this paper
• Temporal Profile and Cell Subtype Distribution of Activated Caspase‐3 Following Experimental Traumatic Brain Injury

  2000cited by this paper
• Poly(ADP-ribose) polymerase localizes to the centrosomes and chromosomes.

  2000cited by this paper
• Characterization of the AMPA‐Activated Receptors Present on Motoneurons

  2000cited by this paper
• NMDA But Not Non-NMDA Excitotoxicity is Mediated by Poly(ADP-Ribose) Polymerase

  2000cited by this paper
• Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis.

  2000cited by this paper
• AMPA Receptor Current Density, Not Desensitization, Predicts Selective Motoneuron Vulnerability

  2000cited by this paper
• Aggregation of ubiquitin and a mutant ALS-linked SOD1 protein correlate with disease progression and fragmentation of the Golgi apparatus.

  2000cited by this paper
• A cellular defense pathway regulating transcription through poly(ADP-ribosyl)ation in response to DNA damage.

  2000cited by this paper
• Neuroprotection by metabotropic glutamate receptor agonists on kainate-induced degeneration of motor neurons in spinal cord slices from adult rat.

  2000cited by this paper
• A Fast Signal–Induced Activation of Poly(Adp-Ribose) Polymerase

  2000cited by this paper
• Effects of Oxidative Stress on Phospholipid Signaling in Rat Cultured Astrocytes and Brain Slices

  2000cited by this paper
• TGF-beta1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages.

  2000cited by this paper
• Aggregates of mutant protein appear progressively in dendrites, in periaxonal processes of oligodendrocytes, and in neuronal and astrocytic perikarya of mice expressing the SOD1(G93A) mutation of familial amyotrophic lateral sclerosis.

  2000cited by this paper
• DNA damage and activated caspase-3 expression in neurons and astrocytes: evidence for apoptosis in frontotemporal dementia.

  2000cited by this paper
• A receptor for advanced glycosylation endproducts (AGEs) is colocalized with neurofilament-bound AGEs and SOD1 in motoneurons of ALS: immunohistochemical study.

  1999cited by this paper
• Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism.

  1999cited by this paper
• Neuronal accumulation of poly(ADP‐ribose) after brain ischaemia

  1999cited by this paper
• Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease.

  1999influential reference
• Astrocytes prevent neuronal death induced by reactive oxygen and nitrogen species

  1999cited by this paper
• Remarkable increase in cerebrospinal fluid 3‐nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis

  1999cited by this paper
• Prevention of oxidant-induced cell death in Caco-2 colon carcinoma cells after inhibition of poly(ADP-ribose) polymerase and Ca2+ chelation: involvement of a common mechanism.

  1999cited by this paper
• Influence of calcium and iron on cell death and mitochondrial function in oxidatively stressed astrocytes

  1999cited by this paper
• Implication of Poly(ADP‐Ribose) Polymerase (PARP) in Neurodegeneration and Brain Energy Metabolism: Decreases in Mouse Brain NAD+ and ATP Caused by MPTP Are Prevented by the PARP Inhibitor Benzamide

  1999cited by this paper
• Signaling myopia

  1999cited by this paper
• Cultured motor neurons possess calcium-permeable AMPA/kainate receptors.

  1999cited by this paper
• Oxidative stress‐induced metabolic alterations in rat brain astrocytes studied by multinuclear NMR spectroscopy

  1999cited by this paper
• Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion.

  1999cited by this paper
• SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter

  1999cited by this paper
• Amyotrophic Lateral Sclerosis Associated with Genetic Abnormalities in the Gene Encoding Cu/Zn Superoxide Dismutase: Molecular Pathology of Five New Cases, and Comparison with Previous Reports and 73 Sporadic Cases of ALS

  1998cited by this paper
• Presence of 4‐hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis

  1998cited by this paper
• Role of peroxynitrite and neuronal nitric oxide synthase in the activation of poly(ADP-ribose) synthetase in a murine model of cerebral ischemia-reperfusion.

  1998cited by this paper
• Peroxynitrite and Hydrogen Peroxide Induced Cell Death in the NSC34 Neuroblastoma × Spinal Cord Cell Line: Role of Poly(ADP‐Ribose) Polymerase

  1998cited by this paper
• Apoptosis and expression of DNA repair proteins in ischaemic brain injury in man

  1998cited by this paper
• Protein Oxidative Damage in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis

  1998cited by this paper
• Hydrogen peroxide‐induced motoneuron apoptosis is prevented by poly ADP ribosyl synthetase inhibitors

  1998cited by this paper
• Relationship of oxygen radical‐induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS

  1998cited by this paper
• Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death.

  1998cited by this paper
• Protein modification by the lipid peroxidation product 4‐hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients

  1998cited by this paper
• Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.

  1998cited by this paper
• Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide.

  1998cited by this paper
• Effect of Glutamate on Dendritic Growth in Embryonic Rat Motoneurons

  1998cited by this paper
• Protective effects of 5-iodo-6-amino-1,2-benzopyrone, an inhibitor of poly(ADP-ribose) synthetase against peroxynitrite-induced glial damage and stroke development.

  1998cited by this paper
• Glutamate Potentiates the Toxicity of Mutant Cu/Zn-Superoxide Dismutase in Motor Neurons by Postsynaptic Calcium-Dependent Mechanisms

  1998cited by this paper
• Journal Club: Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia

  1998cited by this paper
• Calcium‐permeable α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid receptors: A molecular determinant of selective vulnerability in amyotrophic lateral sclerosis

  1997cited by this paper
• ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

  1997cited by this paper
• Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis

  1997cited by this paper
• Ischemic Brain Injury is Mediated by the Activation of Poly(ADP-Ribose)Polymerase

  1997cited by this paper
• Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis.

  1997cited by this paper
• Increased 3‐nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis

  1997cited by this paper
• Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia

  1997cited by this paper
• Evidence for DNA damage in amyotrophic lateral sclerosis.

  1996cited by this paper
• Astrocytes protect neurons from hydrogen peroxide toxicity

  1996cited by this paper
• Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND.

  1996cited by this paper
• Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis.

  1996cited by this paper
• Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice.

  1996cited by this paper
• Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study.

  1996cited by this paper
• Intense Superoxide Dismutase‐1 Immunoreactivity in Intracytoplasmic Hyaline Inclusions of Familial Amyotrophic Lateral Sclerosis with Posterior Column Involvement

  1996cited by this paper
• Exposure of Astrocytes to Hypoxia/Reoxygenation Enhances Expression of Glucose‐Regulated Protein 78 Facilitating Astrocyte Release of the Neuroprotective Cytokine Interleukin 6

  1996cited by this paper
• Peroxynitrite Inhibits Glutamate Transporter Subtypes (*)

  1996cited by this paper
• Oxidative damage to protein in sporadic motor neuron disease spinal cord

  1995cited by this paper
• Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis.

  1995cited by this paper
• Poly(ADP‐Ribose) Synthetase Activation: An Early Indicator of Neurotoxic DNA Damage

  1995cited by this paper
• Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

  1995cited by this paper
• Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.

  1995cited by this paper
• Cu/Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis.

  1994cited by this paper
• Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes

  1994cited by this paper
• Poly(ADP-ribose) polymerase: a molecular nick-sensor.

  1994cited by this paper
• Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity.

  1994cited by this paper
• Superoxide Dismutase Activity, Oxidative Damage, and Mitochondrial Energy Metabolism in Familial and Sporadic Amyotrophic Lateral Sclerosis

  1993cited by this paper
• Neuroprotection against nitric oxide injury with inhibitors of ADP-ribosylation.

  1993cited by this paper
• Trophic support of motoneurons: physiological, pathophysiological, and therapeutic implications.

  1993cited by this paper
• Role of poly(ADP-ribose) formation in DNA repair

  1992cited by this paper
• Atrophic Cell Processes of Large Motor Neurons in the Anterior Horn in Amyotrophic Lateral Sclerosis: Observation with Silver Impregnation Method

  1987cited by this paper
• Oxidant injury of cells.

  1987cited by this paper
• DNA strand breaks, NAD metabolism, and programmed cell death.

  1986cited by this paper
• Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase.

  1986cited by this paper
• Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide.

  1986cited by this paper
• Poly(ADP-ribose) in the cellular response to DNA damage.

  1985cited by this paper
• Adult rat brain astrocytes support survival of both NGF-dependent and NGF-insensitive neurones

  1979cited by this paper

• Tipping the PARylation scale: Dysregulation of PAR signaling in Huntington and neurodegenerative diseases

  2025cites this paper
• Antibodies against SARS-CoV-2 non-structural protein 3 cross-react with human muscle cells and neuroglial cells.

  2024cites this paper
• Using Redox Proteomics to Gain New Insights into Neurodegenerative Disease and Protein Modification

  2024cites this paper
• Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases

  2023cites this paper
• Early nuclear phenotypes and reactive transformation in human iPSC-derived astrocytes from ALS patients with SOD1 mutations

  2023cites this paper
• Poly (ADP-ribose) polymerases as PET imaging targets for central nervous system diseases

  2022influential citation
• The Complex Mechanisms by Which Neurons Die Following DNA Damage in Neurodegenerative Diseases

  2022cites this paper
• PARP overactivation in neurological disorders

  2021cites this paper
• DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity

  2021cites this paper
• Biomolecular Modifications Linked to Oxidative Stress in Amyotrophic Lateral Sclerosis: Determining Promising Biomarkers Related to Oxidative Stress

  2021cites this paper
• [Poly adenosine diphosphate-ribosylation and neurodegenerative diseases].

  2020cites this paper
• Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review

  2020cites this paper
• Tetramethylpyrazine nitrone improves motor dysfunction and pathological manifestations by activating the PGC-1α/Nrf2/HO-1 pathway in ALS mice.

  2020cites this paper
• New insights of poly(ADP-ribosylation) in neurodegenerative diseases: A focus on protein phase separation and pathologic aggregation.

  2019cites this paper
• Leserbrief

  2018cites this paper
• The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression.

  2018cites this paper
• Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis

  2018cites this paper
• Cell Death Mechanisms of Neurodegeneration.

  2017cites this paper
• The Role of Caffeine in Neurodegenerative Diseases: Possible Genetic and Cellular Signaling Mechanisms

  2015cites this paper
• The new insight on the regulatory role of the vitamin D3 in metabolic pathways characteristic for cancerogenesis and neurodegenerative diseases.

  2015cites this paper
• Pathophysiological Role of Peroxynitrite Induced DNA Damage in Human Diseases: A Special Focus on Poly(ADP-ribose) Polymerase (PARP)

  2015cites this paper
• Parthanatos: mitochondrial‐linked mechanisms and therapeutic opportunities

  2014influential citation
• Roles of vitamin D in amyotrophic lateral sclerosis: possible genetic and cellular signaling mechanisms

  2013cites this paper
• Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

  2013cites this paper
• Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

  2013cites this paper
• Mitochondria, calcium-dependent neuronal death and neurodegenerative disease

  2012cites this paper
• Brief Review of the Role of Glycogen Synthase Kinase-3β in Amyotrophic Lateral Sclerosis

  2011cites this paper
• Homocysteine levels and amyotrophic lateral sclerosis: A possible link

  2010cites this paper
• Poly(ADP‐ribose)polymerase inhibitor can attenuate the neuronal death after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced neurotoxicity in mice

  2009cites this paper
• Persistent cleavage and nuclear translocation of apoptosis-inducing factor in motor neurons in the spinal cord of sporadic amyotrophic lateral sclerosis patients

  2009cites this paper
• PARP activation and inflammatory reaction in selective neurodegeneration.

  2008cites this paper
• [Neuronal death in amyotrofic lateral sclerosis].

  2008cites this paper
• Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.

  2008cites this paper
• Nuclear receptor coregulators and human disease.

  2008cites this paper
• Role of Poly(ADP-ribose) Polymerase in Brain Inflammation and Neuroinjury

  2008cites this paper
• Selective overexpression of γ1 laminin in astrocytes in amyotrophic lateral sclerosis indicates an involvement in ALS pathology

  2007cites this paper
• DNA repair, mitochondria, and neurodegeneration.

  2007cites this paper
• Glycogen synthase kinase-3β activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells

  2007cites this paper
• Strategies to prevent motoneuron degeneration in models of Amyotrophic Lateral Sclerosis.

  2006cites this paper
• The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice.

  2006cites this paper
• AIF translocates to the nucleus in the spinal motor neurons in a mouse model of ALS.

  2006cites this paper
• Implications for the Kynurenine Pathway and Quinolinic Acid in Amyotrophic Lateral Sclerosis

  2006cites this paper
• Cytoprotective Effect of 15-deoxy-Delta(12,14) Prostaglandin J2 (15d-PGJ2) against H2O2 Induced Death of Neuronally-differentiated PC12 Cells.

  2006cites this paper
• Role of GSK‐3β activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene

  2005influential citation
• 3-NP-induced neurodegeneration studies in experimental models of Huntington's disease : apoptosis in Huntington's disease

  2005cites this paper
• Role of Glycogen Synthase Kinase-3 in Motor Neuronal Cell Death Mechanism of in Vitro Familial ALS Model (G94A, A4V mutant motoneuron)

  2005cites this paper
• Expression pattern of apoptosis-related markers in Huntington’s disease

  2005cites this paper
• Phosphatidylinositol 3-kinase activator reduces motor neuronal cell death induced by G93A or A4V mutant SOD1 gene.

  2005cites this paper
• Differential effects of diallyl disulfide on neuronal cells depend on its concentration.

  2005cites this paper
• Protective effect of diallyl disulfide on oxidative stress-injured neuronally differentiated PC12 cells.

  2005cites this paper
• The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals

  2004cites this paper
• The expression of PARP, NF-kappa B and parvalbumin is increased in Parkinson disease.

  2004cites this paper
• Reactive astrocytes express PARP in the central nervous system of SOD(G93A) transgenic mice.

  2004cites this paper
• Widespread increased expression of the DNA repair enzyme PARP in brain in ALS

  2004cites this paper
• Neuroprotective effects of ONO-1924H, an inhibitor of poly ADP-ribose polymerase (PARP), on cytotoxicity of PC12 cells and ischemic cerebral damage.

  2004cites this paper
• The expression of PARP, NF-κB and parvalbumin is increased in Parkinson disease

  2004cites this paper
• Phosphatidylinositol-3 kinase/Akt and GSK-3 mediated cytoprotective effect of epigallocatechin gallate on oxidative stress-injured neuronal-differentiated N18D3 cells.

  2004cites this paper
• Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu/Zn-superoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signals.

  2004cites this paper
• Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3.

  2003cites this paper